Trial Profile
A Phase I Clinical Study, Multiple Dose of LCB01-0371 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Apr 2024
Price :
$35
*
At a glance
- Drugs Delpazolid (Primary)
- Indications Bacterial infections; Gram-positive infections
- Focus Adverse reactions
- Sponsors LegoChem Biosciences
- 23 Oct 2017 Results published in the Journal of Antimicrobial Chemotherapy
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 07 Sep 2015 New trial record